BOSTON, April 4, 2017 /PRNewswire/ -- InfoBionic (www.infobionic.com) today announced that Stuart Long was named Chief Executive Officer, underscoring the Company's commitment to widespread market adoption of its transformative wireless remote patient monitoring platform for chronic disease management.
"InfoBionic is redefining the 'standard of care' for patients and physicians alike with its remote, full-disclosure cardiac monitoring platform," said Al Wiegman, Chairman of the Board at InfoBionic. "The Company has demonstrated traction with an influential base of cardiologists and electrophysiologists since receiving FDA approval last year, yet will benefit from Stuart's extensive leadership skills and expertise in medical devices and digital health as the Company looks to scale-up commercialization and expand its operations. We are bullish on the opportunity that lies ahead for InfoBionic and look forward to supporting the team as it continues to push the boundaries on innovation."
With more than 20 years of experience in the medical device market, Stuart brings a great deal of expertise in achieving rapid commercial growth. Prior to joining InfoBionic, he was CEO at Monarch Medical Systems, LLC, a Charlotte-based, artificial intelligence clinical decision support software provider for insulin dosing calculations, where he oversaw the organizational restructuring of the company. Prior to Monarch, Stuart served as the global chief marketing and sales officer for CapsuleTech, Inc., a medical device integration and clinical data management system for hospitals and healthcare institutions. During his tenure, he developed and executed a strategic business and product plan that ultimately led to the company's acquisition by Qualcomm Life, Inc., a subsidiary of Qualcomm, Inc. Prior to CapsuleTech, Stuart worked in executive leadership at Philips Healthcare, overseeing global product management and marketing for their healthcare imaging and informatics group as well as emerging markets in the company's cardiac monitoring division. Stuart also held executive positions at healthcare IT-focused companies including Agfa Healthcare, AMICAS, FUJIFILM USA and Eastman Kodak in addition to his previous clinical experience of managing acute care, non-invasive cardiology.
"In my experience, when you empower the hands-on healthcare provider, you have the opportunity to derive the best possible outcome for the patient," said Stuart. "InfoBionic's founding was predicated around improving patient care by implementing disruptive solutions in today's modern healthcare market. I look forward to building upon my years of service within the healthcare community, and to scaling this innovative platform to support the evolving remote cardiac monitoring needs of the future. The InfoBionic team has done a remarkable job understanding customer needs in the arrhythmia detection and monitoring arena and developing a truly innovative product and business model to address those needs. The InfoBionic platform is uniquely positioned to empower the healthcare practitioner as it turns existing models upside down and uniquely addresses the core issues of quality, functionality, reliability and reimbursement."
InfoBionic is a digital health company focused on creating superior patient monitoring solutions for chronic disease management with an initial market focus on cardiac arrhythmias. InfoBionic is backed by Safeguard Scientifics (NYSE: SFE), Excel Venture Management; Zaffre Investments, a subsidiary of Blue Cross Blue Shield of Massachusetts; and various angels. For more information please visit www.infobionic.com.
SOURCE InfoBionic, Inc.